Rasmussen, A K, Nielsen, H, Andersen, V et al. · Ugeskrift for laeger · 1994
This study compared immune system markers in 21 people with ME/CFS to 21 healthy people matched by age and sex. Researchers found that certain immune cells in ME/CFS patients produced higher levels of specific immune signaling molecules, while antibody levels were slightly lower than normal. Overall, the study did not find clear evidence that ME/CFS is caused by a persistent viral infection or a severely damaged immune system.
This study contributes to understanding whether ME/CFS has an immune basis and whether persistent viruses drive the condition. Finding both elevated and reduced immune markers suggests ME/CFS involves immune dysfunction rather than simple immune deficiency or activation, which informs research into mechanisms and potential therapeutic targets.
This study does not establish whether the observed immune differences are a cause of ME/CFS or a consequence of the disease. The cross-sectional design cannot determine whether immune changes precede symptom onset or develop afterward. Small sample size and lack of longitudinal follow-up limit generalizability and ability to track immune changes over time.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.